Financial News
Lineage Cell Therapeutics Inc (NY: LCTX )
0.9481
+0.0560
(+6.28%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Lineage Cell Therapeutics Inc
![](https://mms.businesswire.com/media/20230418005216/en/1765407/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/13/_harley-davidson_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-fingers.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Preview: Lineage Cell Therapeutics's Earnings
March 08, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230330005137/en/1751149/5/CDRFlogo_2012.jpg)
![](https://mms.businesswire.com/media/20230309005324/en/1734405/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20230320005164/en/1741894/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20230306005224/en/1730051/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20230302005045/en/1726458/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/22/lctx_mark_composite_light__8b65a108bf6992160603188cbba15b10.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/25/screenshot_2023-01-25_at_6.41.56_pm.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230222005324/en/1719460/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://www.investors.com/wp-content/uploads/2019/01/stock-gene-03-adobe.jpg)
![](https://mms.businesswire.com/media/20230208005248/en/1708020/5/LINEAGE_2023_RGB_JPG_1740x360.jpg)
![](https://mms.businesswire.com/media/20221110005260/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20221128005145/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_6164.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221103005165/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20221128005217/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29034.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221031005220/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://public.newsdirect.com/188108312/gx9Vz4ME.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19176.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/13/shutterstock_1647340636.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221010005173/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20221004005157/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20221003005286/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.